molecules-logo

Journal Browser

Journal Browser

Advances in the Biosynthesis and Chemical Synthesis of Natural Products

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Organic Chemistry".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 480

Special Issue Editors


E-Mail Website
Guest Editor
School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
Interests: asymmetric synthesis of bioactive natural products; scale synthesis of natural medication molecules; target molecule-oriented novel and efficient synthesis methodology research; development of novel anti-tumor, anti-inflammatory and immunomodulatory drug candidates
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Chemistry, Southwest Jiaotong University, Chengdu 610031, China
Interests: total synthesis; natural products; synthetic methodology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Natural products are an important source of innovative drug discovery for their complex chemical structures and broad biological activities. The biosynthesis and chemical synthesis of natural products play a critical role in the development of new innovative drugs. Meanwhile, the synthesis of natural products is the most active field in organic synthesis and natural product chemistry. Recently, with the quick development of synthetic biology, the biosynthesis of natural products has achieved impressive achievement, which has also inspired organic chemists to develop novel synthetic methodologies and strategies toward the synthesis of bioactive natural products. Following on from these advances, this Special Issue, titled ‘Advances in the Biosynthesis and Chemical Synthesis of Natural Products’, invites the submission of research papers and reviews on the biosynthesis and chemical synthesis of natural products.

Dr. Sihua Hou
Prof. Dr. Yu Peng
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biosynthesis
  • chemical synthesis
  • natural products
  • synthetic methodology
  • synthetic strategy
  • enzyme

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 2900 KiB  
Article
Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase
by Long Yang, Liwei Yi, Bang Gong, Lili Chen, Miao Li, Xiangcheng Zhu, Yanwen Duan and Yong Huang
Molecules 2024, 29(9), 1982; https://doi.org/10.3390/molecules29091982 - 25 Apr 2024
Viewed by 314
Abstract
Chalkophomycin is a novel chalkophore with antibiotic activities isolated from Streptomyces sp. CB00271, while its potential in studying cellular copper homeostasis makes it an important probe and drug lead. The constellation of N-hydroxylpyrrole, 2H-oxazoline, diazeniumdiolate, and methoxypyrrolinone functional groups into [...] Read more.
Chalkophomycin is a novel chalkophore with antibiotic activities isolated from Streptomyces sp. CB00271, while its potential in studying cellular copper homeostasis makes it an important probe and drug lead. The constellation of N-hydroxylpyrrole, 2H-oxazoline, diazeniumdiolate, and methoxypyrrolinone functional groups into one compact molecular architecture capable of coordinating cupric ions draws interest to unprecedented enzymology responsible for chalkophomycin biosynthesis. To elucidate the biosynthetic machinery for chalkophomycin production, the chm biosynthetic gene cluster from S. sp. CB00271 was identified, and its involvement in chalkophomycin biosynthesis was confirmed by gene replacement. The chm cluster was localized to a ~31 kb DNA region, consisting of 19 open reading frames that encode five nonribosomal peptide synthetases (ChmHIJLO), one modular polyketide synthase (ChmP), six tailoring enzymes (ChmFGMNQR), two regulatory proteins (ChmAB), and four resistance proteins (ChmA′CDE). A model for chalkophomycin biosynthesis is proposed based on functional assignments from sequence analysis and structure modelling, and is further supported by analogy to over 100 chm-type gene clusters in public databases. Our studies thus set the stage to fully investigate chalkophomycin biosynthesis and to engineer chalkophomycin analogues through a synthetic biology approach. Full article
Show Figures

Figure 1

Back to TopTop